Insys insurers object to opioid maker’s liquidation plan

Chubb, Liberty and Insys

Chubb and Liberty Mutual, two of the insurers on Insys’s $30mn product liability tower, have objected to the opioid drug manufacturer’s latest liquidation plan, arguing it is unclear about how insurance obligations would be treated.

Want to read this article?

Subscribe for FULL access to this article - and ALL our premium content

For details on how to subscribe or for all commercial opportunities, including advertising, please contact:

Spencer Halladey
Commercial director
Tel: +44 (0) 203 934 6687

Andy Stone
Sales manager
Tel: +44 (0) 203 934 6684

Subscribers get access to:

  • Breaking news by email on all critical issues
  • Trusted analysis and commentary
  • Opinion from market thought-leaders
  • Exclusive data on the industry
  • Daily digital newsletter
  • Full access to our online archive


If you are a subscriber you can SIGN IN now for FULL access